MA JIANJIE has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are DEVELOGEN AG FUR ENTWICKLUNGSB, LOCOMOGENE INC and ANGIOGENETICS SWEDEN AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Organic fine chemistry | |
#5 | IT methods for management | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Animal care | |
#6 | Combinatorial chemistry | |
#7 | Measuring microorganism processes | |
#8 | Data processing systems | |
#9 | Analysing materials | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Ma Jianjie | 11 |
#2 | Weisleder Noah | 9 |
#3 | Cai Chuanxi | 3 |
#4 | Boding Benjamin Scott | 2 |
#5 | Bushart Shawna | 2 |
#6 | Kim Chul-Woo | 1 |
#7 | Ko Jae-Kyun | 1 |
#8 | Cao Chunmei | 1 |
#9 | Lin Peihui | 1 |
#10 | Pan Zui | 1 |
Publication | Filing date | Title |
---|---|---|
US2015110778A1 | Compositions comprising mg53 and methods for the treatment and prevention of airway injury | |
US2012309051A1 | Compositions and methods for preparing recombinant MG53 and methods for optimizing same | |
US2012066125A1 | Computer-based collective intelligence recommendations for transaction review | |
US2011034533A1 | Compositions and methods modulating MG29 for the treatment of diabetes |